Skip to content

Surgical Procedure Efficiency Evaluation stuDy

Surgical Procedure Efficiency Evaluation stuDy (SPEED): Combination Phaco-Vitrectomy Surgeries With UNITY VCS vs. Constellation in a Real-World Operating Room Setting

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07228091
Enrollment
180
Registered
2025-11-14
Start date
2026-02-09
Completion date
2027-03-01
Last updated
2026-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Macular Holes, Macular Pucker, Retinal Detachment, Vitreous Hemorrhage

Keywords

anterior segment ophthalmic surgery, posterior segment ophthalmic surgery

Brief summary

The purpose of this real-world evidence study is to compare surgical procedure times for UNITY® VCS and CONSTELLATION® Vision System.

Detailed description

Eligible subjects will undergo routine scheduled combined anterior-posterior segments surgery (phacovitrectomy). This single visit, time-and-motion study will be conducted in the United Kingdom. This study will be conducted by Alcon Vision LLC.

Interventions

DEVICEUNITY VCS

UNITY® VCS is a CE-marked, FDA-approved ophthalmic microsurgical system that is indicated for both anterior segment (i.e., phacoemulsification and removal of cataracts) and posterior segment (i.e., vitreoretinal) ophthalmic surgery. The focus of this study will be on combined anterior-posterior segments surgery (phacovitrectomy).

DEVICECONSTELLATION

CONSTELLATION is a CE-marked, FDA-approved ophthalmic microsurgical system that is indicated for both anterior segment (i.e., phacoemulsification and removal of cataracts) and posterior segment (i.e., vitreoretinal) ophthalmic surgery. The focus of this study will be on combined anterior-posterior segments surgery (phacovitrectomy).

Sponsors

Alcon Research
Lead SponsorINDUSTRY
Manchester Royal Eye Hospital
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Able to understand and sign an informed consent form (ICF) that has been approved by an ethics committee. * Planned combined phacovitrectomy procedure at one of the selected surgical sites. * Planned combined phacovitrectomy procedure with 25-gauge (G) vitrectomy tools. Key

Exclusion criteria

* Unplanned/emergency phacovitrectomy. * Pregnant. * Past history of phacovitrectomy. cataract, vitrectomy in the planned operative eye. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Proportion of surgeons replying "efficient" or "very efficient" to the question, "How would you rate overall OR (operating room) efficiency of the console for the combined phaco-vitrectomy surgery (including set-up/tear-down)?Up to Day 1 post completion of the surgeryResponses will be collected on a 5-point scale where 1=Very Inefficient, 2=Inefficient, 3=Neutral, 4=Efficient, and 5=Very Efficient.

Countries

United Kingdom

Contacts

CONTACTAlcon Call Center
alcon.medinfo@alcon.com1-888-451-3937
STUDY_DIRECTORManager, Health Economics/Outcomes Research

Alcon Research, LLC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 14, 2026